CPT2 Deficiency Modeled in Zebrafish: Abnormal Neural Development, Electrical Activity, Behavior, and Schizophrenia-Related Gene Expression
Biomolecules · 2024
DOI: 10.3390/biom14080914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Carly E Baker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Creighton University, Omaha, NE 68178, USA. Hauptthemen laut MEDLINE: Zebrafish, Carnitine O-Palmitoyltransferase, Schizophrenia, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Carnitine palmitoyltransferase 2 (CPT2) is an inner mitochondrial membrane protein of the carnitine shuttle and is involved in the beta-oxidation of long chain fatty acids. Beta-oxidation provides an alternative pathway of energy production during early development and starvation. CPT2 deficiency is a genetic disorder that we recently showed can be associated with schizophrenia. We hypothesize that CPT2 deficiency during early brain development causes transcriptional, structural, and functional abnormalities that may contribute to a CNS environment that is susceptible to the emergence of schizophrenia. To investigate the effect of CPT2 deficiency on early vertebrate development and brain function, CPT2 was knocked down in a zebrafish model system. CPT2 knockdown resulted in abnormal lipid utilization and deposition, reduction in body size, and abnormal brain development. Axonal projections, neurotransmitter synthesis, electrical hyperactivity, and swimming behavior were disrupted in CPT2 knockdown zebrafish. RT-qPCR analyses showed significant increases in the expression of schizophrenia-associated genes in CPT2 knockdown compared to control zebrafish. Taken together, these data demonstrate that zebrafish are a useful model for studying the importance of beta-oxidation for early vertebrate development and brain function. This study also presents novel findings linking CPT2 deficiency to the regulation of schizophrenia and neurodegenerative disease-associated genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Creighton University, Omaha, NE 68178, USA.
- Department of Biology, Creighton University, Omaha, NE 68178, USA.
- Department of Pediatrics, Department of Biochemistry & Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68178, USA.
- Department of Pharmacology and Neuroscience, Creighton University, Omaha, NE 68178, USA.
ORCID-Profile: Carly E Baker, Zeljka Korade, Timothy Simeone, Holly A F Stessman
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institute for AIDS and Infectious Disease (NIAID)
- National Institute for General Medical Science (NIGMS)
Zitieren
APA
Baker, C. E., Marta, A. G., Zimmerman, N. D., Korade, Z., Mathy, N. W., Wilton, D., Simeone, T., Kochvar, A., Kramer, K. L., Stessman, H. A. F., & Shibata, A. (2024). CPT2 Deficiency Modeled in Zebrafish: Abnormal Neural Development, Electrical Activity, Behavior, and Schizophrenia-Related Gene Expression. Biomolecules. https://doi.org/10.3390/biom14080914
Vancouver
Baker CE, Marta AG, Zimmerman ND, Korade Z, Mathy NW, Wilton D, et al. CPT2 Deficiency Modeled in Zebrafish: Abnormal Neural Development, Electrical Activity, Behavior, and Schizophrenia-Related Gene Expression. Biomolecules. 2024. doi:10.3390/biom14080914
BibTeX
@article{Baker2024,
author = {Baker, Carly E and Marta, Aaron G and Zimmerman, Nathan D and Korade, Zeljka and Mathy, Nicholas W and Wilton, Delaney and Simeone, Timothy and Kochvar, Andrew and Kramer, Kenneth L and Stessman, Holly A F and Shibata, Annemarie},
title = {CPT2 Deficiency Modeled in Zebrafish: Abnormal Neural Development, Electrical Activity, Behavior, and Schizophrenia-Related Gene Expression},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14080914}
}
EUVIMED